Your session is about to expire
← Back to Search
Anti-viral
Study Participants for Hepatitis C
N/A
Waitlist Available
Led By Timothy I Mercer, MD,MPH
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately one year from date of enrollment of first participant
Awards & highlights
Study Summary
This trial is looking at a new, simplified approach to treating HCV in primary care settings that will hopefully be more effective in engaging and retaining people in care, with the ultimate goal of curing HCV in high-risk populations.
Eligible Conditions
- Hepatitis C
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately one year from date of enrollment of first participant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately one year from date of enrollment of first participant
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of participants with chronic HCV infection enrolled in the study that achieve SVR-12
Secondary outcome measures
Clinical outcome: Complete HCV Treatment
Clinical outcome: Initiate HCV treatment
Clinical outcome: Time to treatment
Other outcome measures
Implementation Outcome: Adoption
Implementation Outcome: Implementation
Implementation Outcome: Maintenance
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Study ParticipantsExperimental Treatment1 Intervention
Persons infected with the hepatitis C virus who meet the study inclusion criteria and do not meet one or more of the exclusion criteria.
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
350 Previous Clinical Trials
80,920 Total Patients Enrolled
Timothy I Mercer, MD,MPHPrincipal InvestigatorThe University of Texas at Austin Dell Medical School
Darlene Bhavnani, PhD MPHPrincipal InvestigatorThe University of Texas at Austin Dell Medical School
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are enrolled in care at one of CommunityCare's clinical sites participating in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Study Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment ongoing for this experiment?
"Affirmative. Examining the research hosted on clinicaltrials.gov, it is apparent that this medical trial has been actively recruiting since September 29th 2022 and recently updated October 3rd 2022. The study requires 289 participants from a single location to be enrolled."
Answered by AI
What is the participant number of this experiment?
"Affirmative, clinicaltrials.gov has records of this trial being open for recruitment since September 29th 2022 and updated on October 3rd 2022. The investigators aim to enrol 289 patients at one medical site."
Answered by AI
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger